journal article·2023-12-12

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics

Dengshuai Wei, Yong Sun, Hu Zhu, Qinrui Fu

ACS Nano· Volume 17· Issue 23
Publisher page

Abstract

Stimuli-responsive polymers can respond to internal stimuli, such as reactive oxygen species (ROS), glutathione (GSH), and pH, biological stimuli, such as enzymes, and external stimuli, such as lasers and ultrasound, etc., by changing their hydrophobicity/hydrophilicity, degradability, ionizability, etc., and thus have been widely used in biomedical applications. Due to the characteristics of the tumor microenvironment (TME), stimuli-responsive polymers that cater specifically to the TME have been extensively used to prepare smart nanovehicles for the targeted delivery of therapeutic and diagnostic agents to tumor tissues. Compared to conventional drug delivery nanosystems, TME-responsive nanosystems have many advantages, such as high sensitivity, broad applicability among different tumors, functional versatility, and improved biosafety. In recent years, a great deal of research has been devoted to engineering efficient stimuli-responsive polymeric nanosystems, and significant improvement has been made to both cancer diagnosis and therapy. In this review, we summarize some recent research advances involving the use of stimuli-responsive polymer nanocarriers in drug delivery, tumor imaging, therapy, and theranostics. Various chemical stimuli will be described in the context of stimuli-responsive nanosystems. Accordingly, the functional chemical groups responsible for the responsiveness and the strategies to incorporate these groups into the polymer will be discussed in detail. With the research on this topic expending at a fast pace, some innovative concepts, such as sequential and cascade drug release, NIR-II imaging, and multifunctional formulations, have emerged as popular strategies for enhanced performance, which will also be included here with up-to-date illustrations. We hope that this review will offer valuable insights for the selection and optimization of stimuli-responsive polymers to help accelerate their future applications in cancer diagnosis and treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, China

Maoming People’s Hospital, Guangdong 525000, China

Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao 266021, China

Funding

Natural Science Foundation of Qingdao Municipality · China Postdoctoral Science Foundation · Taishan Scholar Project of Shandong Province · National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1038/s41565-019-0567-y10.1038/s41565-019-0567-y ↗
2. 10.1038/s41568-022-00496-910.1038/s41568-022-00496-9 ↗
3. 10.1038/s41467-023-39423-310.1038/s41467-023-39423-3 ↗
4. 10.1007/s10311-018-00841-110.1007/s10311-018-00841-1 ↗
5. 10.1021/acsnano.2c0089310.1021/acsnano.2c00893 ↗
6. 10.1002/advs.20210537310.1002/advs.202105373 ↗
7. 10.1016/j.nano.2020.10223710.1016/j.nano.2020.102237 ↗
8. 10.1038/s41573-018-0005-010.1038/s41573-018-0005-0 ↗
9. 10.1038/s41563-020-0647-210.1038/s41563-020-0647-2 ↗
10. 10.1002/adhm.20220268810.1002/adhm.202202688 ↗
11. 10.3390/jpm1108077110.3390/jpm11080771 ↗
12. 10.1039/D1BM01398J10.1039/D1BM01398J ↗
13. 10.1038/s42003-021-01822-x10.1038/s42003-021-01822-x ↗
14. 10.1038/s41467-021-27137-310.1038/s41467-021-27137-3 ↗
15. 10.1038/s41598-023-30026-y10.1038/s41598-023-30026-y ↗
16. 10.3390/molecules2406111710.3390/molecules24061117 ↗
17. 10.1002/adhm.20200112510.1002/adhm.202001125 ↗
18. 10.1021/acs.chemrev.0c0077910.1021/acs.chemrev.0c00779 ↗
19. 10.1038/s41467-018-03705-y10.1038/s41467-018-03705-y ↗
20. 10.1038/s41578-020-00269-610.1038/s41578-020-00269-6 ↗
21. 10.1002/adma.20160662810.1002/adma.201606628 ↗
22. 10.1038/s43586-021-00038-x10.1038/s43586-021-00038-x ↗
23. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
24. 10.1002/mabi.20190041510.1002/mabi.201900415 ↗
25. 10.1038/s41392-020-00247-y10.1038/s41392-020-00247-y ↗
26. 10.1038/s41467-021-23872-910.1038/s41467-021-23872-9 ↗
27. 10.3390/molecules2524598610.3390/molecules25245986 ↗
28. 10.1021/acsabm.2c0017910.1021/acsabm.2c00179 ↗
29. 10.1016/j.heliyon.2022.e0939410.1016/j.heliyon.2022.e09394 ↗
30. 10.1016/j.progpolymsci.2019.06.00210.1016/j.progpolymsci.2019.06.002 ↗
31. 10.1038/s41565-021-00950-z10.1038/s41565-021-00950-z ↗
32. 10.1016/j.ijpharm.2017.09.00510.1016/j.ijpharm.2017.09.005 ↗
33. 10.1016/j.drudis.2020.06.02810.1016/j.drudis.2020.06.028 ↗
34. 10.3390/pharmaceutics1205040610.3390/pharmaceutics12050406 ↗
35. 10.1002/anie.20220799810.1002/anie.202207998 ↗
36. 10.1002/anie.20190748410.1002/anie.201907484 ↗
37. 10.1038/s41598-020-61726-410.1038/s41598-020-61726-4 ↗
38. 10.2147/IJN.S29944810.2147/IJN.S299448 ↗
39. 10.1038/s41578-021-00385-x10.1038/s41578-021-00385-x ↗
40. 10.1021/cm402592t10.1021/cm402592t ↗
41. 10.1016/j.mseb.2020.11483510.1016/j.mseb.2020.114835 ↗
42. 10.1021/acsbiomaterials.1c0093810.1021/acsbiomaterials.1c00938 ↗
43. 10.1038/s41420-023-01490-210.1038/s41420-023-01490-2 ↗
44. 10.1021/acsomega.3c0034210.1021/acsomega.3c00342 ↗
45. 10.2147/IJN.S27909410.2147/IJN.S279094 ↗
46. 10.1016/j.sciaf.2020.e0068510.1016/j.sciaf.2020.e00685 ↗
47. 10.1016/j.addr.2014.12.00410.1016/j.addr.2014.12.004 ↗
48. 10.1038/sj.bjc.660331110.1038/sj.bjc.6603311 ↗
49. 10.1016/j.cclet.2020.11.02910.1016/j.cclet.2020.11.029 ↗
50. 10.1038/s41413-021-00180-y10.1038/s41413-021-00180-y ↗
51. 10.1021/acs.chemrev.7b0016810.1021/acs.chemrev.7b00168 ↗
52. 10.1016/j.cobme.2022.10043710.1016/j.cobme.2022.100437 ↗
53. 10.1021/acs.iecr.9b0068310.1021/acs.iecr.9b00683 ↗
54. 10.1007/s13758-011-0009-310.1007/s13758-011-0009-3 ↗
55. 10.3390/ijms2113472410.3390/ijms21134724 ↗
56. 10.1038/s41427-021-00303-110.1038/s41427-021-00303-1 ↗
57. 10.1002/advs.20200185310.1002/advs.202001853 ↗
58. 10.1038/nmat377610.1038/nmat3776 ↗
59. 10.1016/j.ccr.2021.21426710.1016/j.ccr.2021.214267 ↗
60. 10.3389/fchem.2021.64904810.3389/fchem.2021.649048 ↗
61. 10.1038/s41467-022-32160-z10.1038/s41467-022-32160-z ↗
62. 10.1038/s41578-022-00426-z10.1038/s41578-022-00426-z ↗
63. 10.1038/s12276-021-00599-710.1038/s12276-021-00599-7 ↗
64. 10.1016/j.xcrp.2020.10024510.1016/j.xcrp.2020.100245 ↗
65. 10.1038/s41467-019-09566-310.1038/s41467-019-09566-3 ↗
66. 10.1038/s41392-021-00512-810.1038/s41392-021-00512-8 ↗
67. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
68. 10.1038/s41377-021-00561-210.1038/s41377-021-00561-2 ↗
69. 10.1016/j.addr.2012.11.00410.1016/j.addr.2012.11.004 ↗
70. 10.1038/s41579-019-0313-310.1038/s41579-019-0313-3 ↗
71. 10.1002/advs.20210054010.1002/advs.202100540 ↗
72. 10.1038/s41551-019-0436-x10.1038/s41551-019-0436-x ↗
73. 10.1038/s41578-021-00315-x10.1038/s41578-021-00315-x ↗
74. 10.1038/s41529-022-00277-710.1038/s41529-022-00277-7 ↗
75. 10.1038/s41571-021-00539-410.1038/s41571-021-00539-4 ↗
76. 10.1038/s42255-020-00317-z10.1038/s42255-020-00317-z ↗
77. 10.1016/j.critrevonc.2021.10328510.1016/j.critrevonc.2021.103285 ↗
78. 10.1038/s41392-020-00280-x10.1038/s41392-020-00280-x ↗
79. 10.1021/acsami.3c0030710.1021/acsami.3c00307 ↗
80. 10.1038/s41596-020-00421-010.1038/s41596-020-00421-0 ↗
81. 10.1038/s12276-021-00640-910.1038/s12276-021-00640-9 ↗
82. 10.1021/acs.bioconjchem.1c0038510.1021/acs.bioconjchem.1c00385 ↗
83. 10.1002/adhm.20200038710.1002/adhm.202000387 ↗
84. 10.1002/advs.20210383610.1002/advs.202103836 ↗
85. 10.1016/B978-0-12-420117-0.00001-310.1016/B978-0-12-420117-0.00001-3 ↗
86. 10.1021/acs.chemrev.7b0016110.1021/acs.chemrev.7b00161 ↗
87. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
88. 10.1038/s42255-022-00591-z10.1038/s42255-022-00591-z ↗
89. 10.1007/s40820-019-0347-010.1007/s40820-019-0347-0 ↗
90. 10.1038/s41467-021-24329-910.1038/s41467-021-24329-9 ↗
91. 10.1016/j.jiec.2021.04.01610.1016/j.jiec.2021.04.016 ↗
92. 10.1021/acs.macromol.2c0087910.1021/acs.macromol.2c00879 ↗
93. 10.1021/acsmacrolett.7b0001510.1021/acsmacrolett.7b00015 ↗
94. 10.1002/mabi.20150044010.1002/mabi.201500440 ↗
95. 10.1002/advs.20160012410.1002/advs.201600124 ↗
96. 10.1021/acs.biomac.1c0121010.1021/acs.biomac.1c01210 ↗
97. 10.1021/acsnano.0c0619010.1021/acsnano.0c06190 ↗
98. 10.1038/s42004-020-0286-110.1038/s42004-020-0286-1 ↗
99. 10.1021/jacs.7b0092910.1021/jacs.7b00929 ↗
100. 10.1038/s41467-021-20920-210.1038/s41467-021-20920-2 ↗